Evaluation of Efficacy and Toxicity of Nivolumab Monotherapy for Advanced Non-small Cell Lung Cancer After First-line Treatment Failure Based on Second-generation Sequencing and Liquid Chip Platform

Clinical trial NCT03692442 · UNKNOWN

Trial details

NCT number: NCT03692442
Sponsor: Guangzhou Institute of Respiratory Disease
Status: UNKNOWN
Study type: OBSERVATIONAL

Lung Cancer Non-small Cell Stage IV

Start date: 2018-05-01
Primary completion: 2019-01-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.